Inhibition of soybean lipoxygenase by SKF 525-A and metyrapone

To determine whether agents which inhibit cytochrome P-450 enzymes also inhibit lipoxygenase, the effects of metyrapone and SKF 525-A were assessed on soybean lipoxygenase using a spectrophotometric technique which allows for measurement of both the rate and magnitude of product formation. Both SKF 525-A and metyrapone inhibited the rate of product formation and the final amount of product formed in 5 min incubations SKF 525-A was 5 to 6 times more potent than metyrapone, with the IC₅₀ for SKF 525-A 40 uM and for metyrapone between 150 and 200 uM as determined by the total product formation in 5 minutes. Analysis of the reduced product by HPLC confirmed that the substances monitored were those generated by the 15-lipoxygenase enzyme.     

Inhibition of lipoxygenase enzyme in vitro by the cytochrome P-450 inhibitors metyrapone and SKF-525-A

It has recently been demonstrated that agents which block lipoxygenase enzymes (i.e. nordihydroguaiaretic and eicosatetraynoic acid) also block cytochrome P-450 in some $\text{in vitro}$ preparations. In some cases, therefore, results which were based on these lipoxygenase inhibitors could have been produced by the inhibition of cytochrome P-450. We therefore sought a way to distinguish between effects produced by metabolites of arachidonic acid generated by lipoxygenase enzymes and those produced by metabolites of the cytochrome P-450 system. seemed that a straightforward approach might be to administer drugs that inhibit the cytochrome P-450 system first, and then examine effects of lipoxygenase inhibitors. However, it then became necessary to establish the effect of inhibitors of the cytochrome P-450 system on lipoxygenase enzymes. Initial work was carried out using crystalline soybean lipoxygenase enzyme to avoid the complexities involved in isolating enzymes from biological tissues.Enzyme activity was assessed spectrophotometrically by measuring the increase in absorbance at 240 nm produced by the formation of a conjugated triene (15-HETE) from arachidonic acid. Effects of the two most commonly used cytochrome P-450 antagonists, metyrapone and SKF-525A, were determined by Lineweaver-Burke analysis. One major difficulty was that arachidonic acid is soluble in aqueous media at Ph 8 whereas both SKF-525-A and metyrapone are soluble at pH 7. In order to maintain all components in solution at the same time, experiments were carried out at pH 7.35 in the presence of 5% dimethylsulfoxide. There was no observable difference in the activity of 15-lipoxygenase at pH 9 in the absence of DMSO and that observed at pH 7.35 in the presence of DMSO.Studies were carried out in 2 ml quartz spectrophotometer cuvettes. For each experiment, two cuvettes were prepared containing arachidonic acid, DMSO (0.1 ml), SKF-525-A or metyrapone, and Tris buffer (pH 7.35). The cuvettes were placed in a Beckman DB/G spectrophotometer. One cuvette was used as reference and to the other was added 3ug (0.1 ml) of a solution of crystalline soybean lipoxygenase (Sigma). The change in absorbance at 240 nm was recorded and reflected product formation. Concentrations of arachidonic acid ranged from 10–50 uM, each tube contained either 0–50 uM SKF-525-A or 0–200 uM metyrapone.Results show that both SKF-525-A and metyrapone inhibited soybean lipoxygenase. Lineweaver-Burke analysis indicated that both agents acted in uncompetitive fashion. Of particular importance is that these concentrations of SKF-525-A and metyrapone are similar to those routinely used to block cytochrome P-450. From these results, it appears that experiments in which SKF-525-A and metyrapone were employed may need to be reevaluated. Work is underway using platelet-derived 12-lipoxygenase.     

Degradation of aflatoxin by Aspergillus flavus

Aflatoxin degradative activity was demonstrated in 6- to 12-d-old intact mycelium and cell-free extracts of Aspergillus flavus. The addition of cycloheximide, SKF 525-A or metyrapone to cultures of A. flavus prevented subsequent degradation of the aflatoxins, while in cell-free extracts degradation was inhibited by SKF 525-A, metyrapone and cytochrome c but not by KCN. In cell-free extracts, aflatoxin degradation was enhanced by NADPH and NaIO4. The results suggest the involvement of cytochrome P-450 monooxygenases in the aflatoxin degradative activity of A. flavus.     

An indirect thyroxine stimulation of microsomal fatt acid desaturation in vitro.

Metabolically active intestinal epithelial cells were isolated using collagenase plus hyaluronidase. Oxygen consumption was measured and was found to be inhibited by KCN, antimycin A, and rotenone. Cells from 3-methylcholanthrene(MC)-treated rats metabolized benzo(α)pyrene (BP) at a rate that was 30-fold greater than control cells. The addition of salicylamide to the incubation medium inhibited conjugation of BP metabolites and facilitated the accumulation of fluorescent and ethylacetate extractable metabolites. Metyrapone, SKF 525-A, α-naphthoflavone (α-NF), and rotenone inhibited BP-metabolism in intestinal cells from MC-treated rats, with α-NF being the most inhibitory. In intestinal cells from control animals, metyrapone and SKF 525-A both inhibited BP metabolism, while α-NF and rotenone both produced an increase in the formation of fluorescent BP products. The distribution of metabolites from MC-treated rats was determined by high-pressure liquid chromatography and compared with authentic BP derivatives. Incubations were conducted for 5 and 30 min in the presence and absence of salicylamide, and 30-min samples incubated in the absence of salicylamide were hydrolyzed with β-glucuronidase or aryl sulfatase. In the absence of salicylamide, large amounts of conjugates were formed, the formation of which were inhibited by salicylamide addition. A product corresponding to the 4,5-oxide constituted the major metabolite after a 5-min incubation, while little dihydrodiol formation occurred. Large amounts of phenolic BP derivatives were also formed. After 30-min incubations, the percentage of products corresponding to the 4,5-oxide decreased, and an increase in dihydrodiol formation was observed. The slow metabolism of the 4,5-oxide and the slow accumulation of dihydrodiols is due to the presence of low epoxide hydrase activity in the intestine. Intestinal cells are capable of xenobiotic metabolism, and offer a convenient method of studying intestinal drug metabolizing processes which may significantly contribute to the overall xenobiotic metabolis in the body.     

Comparison of the effects of inhibitors of cytochrome P-450-mediated reactions on human platelet aggregation and arachidonic acid metabolism

Metyrapone and SKF-525A, together with amphenone B, a structural analogue of metyrapone, which are all inhibitors of cytochrome P-450-mediated reactions, were shown to inhibit the arachidonic acid-induced aggregation of human platelets. Amphenone B, like metyrapone, exhibited a type II (ligand) binding spectrum with rat liver microsomal cytochrome P-450, in contrast to SKF 525A which is a type I (substrate) binding agent. Independently of their type of binding spectra and of their maximum spectral change, however, the affinity of the three compounds for rat liver cytochrome P-450 showed a close proportional correlation with their platelet aggregation inhibitory potency. All three compounds inhibited the formation of [1-14C]thromboxane B2 from [1-14C]arachidonic acid by human platelets aggregated with collagen. The effect of metyrapone on the remaining labelled products suggested that it is a selective thromboxane synthesis inhibitor, while amphenone B exhibited activity reminiscent of cyclo-oxygenase inhibitors. SKF 525A produced complex effects possibly attributable to cyclo-oxygenase inhibition and enhanced lipid peroxidation, since it also enhanced platelet malonaldehyde formation, which the other two compounds inhibited. These data provide further support for a role of cytochrome P-450 in thromboxane synthesis and platelet aggregation.     

Inhibition of steroid-mediated induction of δ-aminolevulinic acid synthase by 2-diethylaminoethyl-2,2-diphenylvalerate HCl (SKF 525-A)

The inhibition of the steroid-mediated induction of δ-aminolevulinate synthase, the rate-limiting enzyme in hepatic porphyrin-heme biosynthesis, by 2-diethylaminoethyl-2,2-diphenylvalerate HCl (SKF 525-A) as studied in cultured chick embryo liver cells. The formation of porphyrins in response to cyproterone, a synthetic steroid, was inhibited in a time-dependent manner by SKF 525-A, an inhibitor of several drug metabolizing enzyme systems. This action is a result of an inhibitory effect of SKF 525-A on the cyproterone-mediated induction of δ-aminolevulinate synthase; SKF 525-A laso inhibited the induction of the enzyme by the naturally occurring 5β-H steroids, etiocholanolone and pregnanolone. Employing [³H]etiocholanolone, we provide evidence that this inhibition is not associated with either decreased uptake or an altered metabolism of the steroid. Moreover, approx. 4–6-fold more radioactivity was associated with [³H]etiocholanolone-treated cells cultured in the presence of SKF 525-A. Alternative mechanisms for the induction of δ-aminolevulinate synthase by steroids are proposed which do not require the interaction of steroid-receptor complex with the genome.     

The induction of multiple forms of cytochrome P-450 by SKF 525-A

SKF 525-A induces several subpopulations of cytochrome P-450 which differ in their chromatographic properties and in their abilities to sequester themselves as metabolic-intermediate complexes. The two major subpopulations induced by SKF 525-A have both similar chromatographic elution profiles on DEAE cellulose and the same molecular weight as the two major forms induced by phenobarbital (PB). They differ from those induced by phenobarbital, however, in the extent to which they sequester themselves as SKF 525-A metabolic-intermediate complexes in vivo. They also differ markedly from the major cytochrome induced by beta-naphthoflavone (BNF) which is incapable of forming metabolic-intermediate complexes with SKF 525-A in vivo.     

Comparison of the effects of inhibitors of cytochrome P-450-mediated reations on human platelet aggregation and arachidonic acid metabolism

Metyrapone and SKF-525A, together with amphenone B, a structural analogue of metyrapone, which are all inhibitors of cytochrome P-450-mediated reactiors, were shown to inhibit the arachidonic acid-induced aggregation of human platelets. Amphenone B, like metyrapone, exhibited a type II (ligand) binding spectrum with rat liver microsomal cytochrome P-450, in contrast to SKF 525A which is a type I (substrate) binding agent. Independently of their type of binding spectra and of their maximum spectral change, however, the affinity of the three compounds for rat liver cytochrome P-450 showed a close proportional correlation with their platelet aggregation inhibitory potency. All three compounds inhibited the formation of [1?¹⁴C]thromboxane B₂ from [1?¹⁴C]arachidonic acid by human platelets aggregated with collagen. The effect of metyrapone on the remaining labelled products suggested that it is a selective thromboxane synthesis inhibitor, while amphenone B exhibited activity reminiscent of cyclo-oxygenase inhibitors. SKF 525A produced complex effects possibly attributable to cyclo-oxygenase inhibition and enhanced lipid peroxidation, since it also enhanced platelet malonaldehyde formation, which the other two compounds inhibited. These data provide further support for a role of cytochrome P-450 in thromboxane synthesis and platelet aggregation.     

Complexation of cytochrome P-450 isozymes in hepatic microsomes from SKF 525-A-induced rats

Potassium ferricyanide-elicited reactivation of steroid hydroxylase activities, in hepatic microsomes from SKF 525-A-induced male rats, was used as an indicator of complex formation between individual cytochrome P-450 isozymes and the SKF 525-A metabolite. Induction of male rats with SKF 525-A (50 mg/kg for three days) led to apparent increases in androst-4-ene-3,17-dione 16 beta- and 6 beta-hydroxylation to 6.7- and 3-fold of control activities. Steroid 7 alpha-hydroxylase activity was decreased to 0.8-fold of control and 16 alpha-hydroxylation was unchanged. Ferricyanide-elicited dissociation of the SKF 525-A metabolite-P-450 complex revealed an even greater induction of 16 beta- and 6 beta-hydroxylase activities (to 1.8- and 1.6-fold of activities in the absence of ferricyanide). Androst-4-ene-3,17-dione 16 alpha-hydroxylase activity increased 2-fold after ferricyanide but 7 alpha-hydroxylase activity was unaltered. An antibody directed against the male-specific cytochrome P-450 UT-A decreased androst-4-ene-3,17-dione 16 alpha-hydroxylase activity to 13% of control in hepatic microsomes from untreated rats. In contrast, 16 alpha-hydroxylase activity in microsomes from SKF 525-A-induced rats, before and after dissociation with ferricyanide, was reduced by anti UT-A IgG to 32 and 19% of the respective uninhibited controls. Considered together, these observations strongly suggest that the phenobarbital-inducible cytochrome P-450 isozymes PB-B and PCN-E are present in an inactive complexed state in microsomes from SKF 525-A-induced rat liver. Further, the increased susceptibility of androst-4-ene-3,17-dione 16 alpha-hydroxylase activity to inhibition by an antibody to cytochrome P-450 UT-A, following ferricyanide treatment of microsomes, suggests that this male sexually differentiated enzyme is also complexed after in vivo SKF 525-A dosage. In contrast, the constitutive isozyme cytochrome P-450 UT-F, which is active in steroid 7 alpha-hydroxylation, does not appear to be complexed to any extent in microsomes from SKF 525-A-induced rats.     

Prostacyclin-stimulating drugs: new prospects

SKF 525-A (proadifen), a well-known inhibitor of drug metabolism and cytochrome P-450 activity, stimulated the release of prostacyclin (PGI2) from the rabbit aorta in vitro. The PGI2-stimulating activity of SKF 525-A was characterized by specific structural requirements: activity was abolished by the deletion of the terminal propyl chain and increased by its elongation into an isobutyl chain; chlorination of the phenyl rings increased the potency. SKF 525-A increased the production of PGI2 by cultured endothelial cells from bovine aorta and human umbilical vein, but had no effect on cultured smooth muscle from the bovine aortic media. In human platelets, SKF 525-A inhibited prostaglandin and thromboxane production induced by A23187, thrombin and ADP. Simultaneous stimulation of endothelial PGI2 and inhibition of platelet TxA2 represents an original pharmacological profile: SKF 525-A might thus constitute the prototype of a new class of antiplatelet drugs.     

Prostacyclin-stimulating drugs: New prospects

SKF 525-A (proadifen), a well-known inhibitor of drug metabolism and cytochrome P-450 activity, stimulated the release of prostacyclin (PGI₂) from the rabbit aorta in vitro. The PGI₂-stimulating activity of SKF 525-A was characterized by specific structural requirements : activity was abolished by the deletion of the terminal propyl chain and increased by its elongation into an isobutyl chain; chlorination of the phenyl rings increased the potency. SKF 525-A increased the production of PGI₂ by cultured endothelial cells from bovine aorta and human umbilical vein, but had no effect on cultured smoooth muscle from the bovine aortic media. In human platelets, SKF 525-A inhibited prostaglandin and thromboxane production induced by A23187, thrombin and ADP. Simultaneous stimulation of endothelial PGI₂ and inhibition of platelet TxA₂ represents an original pharmacological profile : SKF 525-A might thus constitute the prototype of a new class of antiplatelet drugs.     

Acute inhibition of microsomal drug metabolism by propoxyphene in narcotic tolerant/dependent mice

Propoxyphene (Darvon) was compared to SKF 525-A, a prototypical inhibitor of hepatic microsomal mixed function oxidases, to assess propoxyphene's potential to inhibit drug metabolism in morphine tolerant/dependent mice. $\text{In vitro}$, both propoxyphene (K_i = 3.5 × 10^?5M) and SKF 525-A (K_i = 4.3 × 10^?6M) inhibited the activity of aminopyrine N-demethylase competitively in hepatic microsomes from tolerant/dependent animals. Propoxyphene and SKF 525-A were weaker, noncompetitive inhibitors of aniline hydroxylase activity. $\text{In vivo}$, equimolar doses (0.24 mmoles/kg, i.p.) of each compound inhibited both of the above monooxygenases in the 10,000$\text{g}$ supernatant fractions of livers from the tolerant/ dependent animals. Propoxyphene was 40–50% as potent an inhibitor of these activities as SKF 525-A. A dose (300 mg/kg) of propoxyphene napsylate, shown to prevent narcotic abstinence signs with no observable toxicity in withdrawing mice, significantly prolonged the blood levels of injected pentobarbital and tripled pentobarbital sleeping time in these animals. When administered at 300 mg/kg chronically, propoxyphene napsylate acted as an inducer of its own metabolism. Propoxyphene napsylate, then, given acutely to narcotic tolerant/dependent mice, is a potent inhibitor of microsomal drug metabolizing capacity. Given chronically, it enhances this capability.     

The involvement of cytochromeP-450 monooxygenase system in aflatoxin biosynthesis byAspergillus flavus

Summary Phenobarbital stimulated aflatoxin biosynthesis byAspergillus flavus and this was paralleled by an increase in microsomal NADPH-cytochromeP-450 reductase and cytochromeP-450 activities. Aflatoxin biosynthesis was inhibited by SKF 525-A, metyrapone and cyanide, inhibitors of the cytochromeP-450 monooxygenase system, further suggesting that aflatoxin biosynthesis byA. flavus could be mediated by a cytochromeP-450 monooxygenase enzyme system.     

Role of cytochrome P-450IIE1 in N-nitroso-N-methylaniline induced hepatocyte cytotoxicity.

1. The cytotoxicity of N-nitrosomethylaniline (NMA) towards hepatocytes isolated from rats was prevented by acetone or ethanol (inhibitors for cytochrome P-450IIE1) but not by metyrapone or SKF525A (inhibitors for cytochrome P-450IIB1/2). Various alcohols, secondary ketones and isothiocyanates that induced cytochrome P-450IIE1 were also found to be protective. Various aromatic and chlorinated hydrocarbon solvents that are substrates or inducers of cytochrome P-450IIE1 also prevented NMA cytotoxicity. Nitrogen-containing heterocycles that induced cytochrome P-450IIE1 were less effective. Further evidence that cytochrome P-450IIE1 was responsible for the activation of NMA was the marked increase in hepatocyte susceptibility if hepatocytes from pyrazole-induced rats were used. 2. NMA was more cytotoxic to hepatocytes isolated from phenobarbital-pretreated rats than uninduced rats. However, metyrapone now prevented and SKF525A delayed the cytotoxicity whereas ethanol, acetone, allyl isocyanate, isoniazid or trichloroethylene had no effect on the susceptibility of phenobarbital-induced hepatocytes. Furthermore, microsomes isolated from phenobarbital-pretreated rats had higher NMA-N-demethylase activity which was more inhibited by metyrapone and SKF525A than that of uninduced microsomal activity. By contrast the N-demethylase activity of phenobarbital induced microsomes was more resistant to acetone, ethanol, hexanal, trichloroethylene and toluene than uninduced microsome. 3. The above results suggest that cytochrome P-450IIE1 catalyses the cytotoxic activation of NMA in normal or pyrazole-induced hepatocytes whereas cytochrome P-450IIB1/2 is responsible for cytotoxicity in phenobarbital-induced hepatocytes.     

Action mechanism of vascular spasmolytics. 5. Drug-related relaxation and adenosine-3',5'-monophosphate content of isolated coronary arteries under conditions of fluoride-induced contracture]

Tetracaine and SKF 525-A as well as stimulators of adenylate cyclase and inhibitors of the nucleoside-3',5'-monophosphate phosphodiesterase have spasmolytic effects. At the fluoride-iuduced contracture -- a form of contracture independent of extracellular calcium -- tetracaine and SKF 525-A effect an additional increase in muscular tension. Their relaxing effect evidently presupposes a functioning calcium exchange. Drugs acting on the cAMP system have invariably spasmolytic effects at this contracture model, although they produced no change of the cAMP content under these conditions. An increase in total cAMP content is not obviously a necessary condition for the occurrence of drug-induced relaxation.     

Cytochrome P-450 and aryl hydroxylase activity in cells of a long-term transplantable tumor

A functionally active system of microsomal monooxygenases has been found in a long-term transplanted tumor MC-II of C57B1/6j mice. In microsomal fraction of the tumor, one could detect cytochrome P-450 and benzo(a)pyrene hydroxylase (BP hydroxylase) activity. The latter one increased more than 2 times after the animals received 3-MC and aroclor 1254. In in-vitro experiments, the microsomal monooxygenase inhibitors, SKF 525-A and metyrapone, did not affect BP hydroxylation, whereas alpha-naphthoflavone inhibited the enzyme. It is assumed that tumor MC-II contains hemoprotein that is similar to cytochrome P1-450.     

Effects of Ca2+/Mg2+ chelators, SKF 525-A and rotenone on phytochrome-mediated betacyanin formation in Amaranthus seedlings

The effects of EDTA, EGTA, SKF 525-A (a selective inhibitor of cytochrome P-450) and rotenone were studied in betacyanin induction by 6 h red and 5 min far-red light, using etiolated, three-day-old Amaranthus caudatus L. half-seedlings. With 0.1 m M EDTA, EGTA and rotenone, and with 10 μ M SKF 525-A, mainly the far-red reversible betacyanin induction by red light was suppressed. Only in 0.1 m M rotenone was about 50% of that effect compensated by an increased far-red irreversible betacyanin induction. An unspecific inhibition was obtained with 0.1 m M SKF 525-A in both control and illuminated plants.
These results are consistent with the view that red light, but not far-red, causes Ca²⁺ efflux from both mitochondria and cytoplasm, whereas Ca²⁺ uptake is indicated mainly after illumination. The resulting switch in the coupling of the mitochondrial electron transport to a Ca²⁺ dependent one in cytochrome P-450 system via respiratory complex 1, appears to be responsible for the far-red reversibility. However, the bulk of the high irradiance reaction seems to be related to another secondary messenger, alternative to Ca²⁺.     

Restoration of hydroperoxide-dependent lipid peroxidation by 3-methylcholanthrene induction of cytochrome P-448 in hepatoma microsomes

Microsomal membranes from the slow-growing Morris hepatoma 9618A catalyze, in the presence of t-butyl hydroperoxide, lower rates of lipid peroxidation than rat liver microsomes. The cytochrome P-450 content of hepatoma microsomes is about 40% that of the liver. SKF 525-A, an inhibitor of mixed-function oxidase, produces in hepatoma microsomes a P-450 type I binding spectrum similar to that of hepatic microsomes. The concentration of the inhibitor required for half-maximal spectral change is about 2 microM in both microsome types. SKF 525-A or ethylmorphine inhibit lipid peroxidation of normal and tumor microsomes to the same extent (about 60%). Treatment of the tumor-bearing rats with 3-methylcholanthrene increases the hepatoma cytochrome P-450 to values comparable to those of control membranes, although the hemoprotein has a peak in the CO-reduced difference absorption spectrum at 448 nm. The cytochrome P-448 induction is accompanied by an almost complete restoration of the hydroperoxide-dependent lipid peroxidation.     

Aldrin epoxidation catalyzed by purified rat-liver cytochromes P-450 and P-448. High selectivity for cytochrome P-450

Aldrin epoxidation was studied in monooxygenase systems reconstituted from purified rat liver microsomal cytochrome P-450 or P-448, NADPH-cytochrome c reductase, dilauroylphosphatidylcholine and sodium cholate. Cytochrome P-450, purified from hepatic microsomes of phenobarbital-treated rats, exhibited a high rate of dieldrin formation. The low enzyme activity observed in the absence of the lipid and sodium cholate was increased threefold by addition of dilauroylphosphatidylcholine and was further stimulated twofold by addition of sodium cholate. The apparent Km for aldrin in the complete system was 7 +/- 2 microM. SKF 525-A, at a concentration of 250 microM, inhibited aldrin epoxidation by 65%, whereas 7,8-benzoflavone had no inhibitory effect at concentrations up to 250 microM. Addition of ethanol markedly increased epoxidase activity. The increase was threefold in the presence of 5% ethanol. When cytochrome P-448 purified from hepatic microsomes of 3-methylcholanthrene-treated rats was used, a very low rate of epoxidation was observed which was less than 3% of the activity mediated by cytochrome P-450 under similar assay conditions. Enzyme activity was independent of the lipid factor dilauroylphosphatidylcholine. The apparent Km for aldrin was 27 +/- 7 microM. The modifiers of monooxygenase reactions, 7,8-benzoflavone, SKF 525-A and ethanol, inhibited the activity mediated by cytochrome P-448. The I50 was 0.05, 0.2 and 800 mM, respectively. These results indicate that aldrin is a highly selective substrate for cytochrome P-450 species present in microsomes of phenobarbital-treated animals and is a poor substrate for cytochrome P-448. The two forms of aldrin epoxidase can be characterised by their turnover number, their apparent Km and their sensitivity to modifiers, like 7,8-benzoflavone and ethanol.     

Reductive metabolism of 1,1,1,2-tetrachloroethane and related chloroethanes by rat liver microsomes

The susceptibility of polychlorinated ethanes to reductive metabolism was evaluated by measuring the amount of each compound consumed during anaerobic incubations with rat live microsomes; 1,1,1,2-tetrachloroethane, pentachloroethane and hexachloroethane were metabolized extensively, 1,1,1,2-tetrachloroethane and the trichloroethanes were metabolized very slowly and the dichloroethanes were not metabolized at a detectable rate. The electron affinity of the chloroethanes was determined by measuring electrochemical half-wave reduction potentials. Chloroethanes with an E1/2 of - 1.35 V or less negative were reduced readily in microsomes while those with an E1/2 equal to or more negative than -1.90 V were not good substrates for enzymatic reduction. Metabolites produced from 1,1,1,2-tetrachloroethane in vitro were 1,1-dichloroethylene (DCE) and 1,1,2-trichloroethane (TCEA) and the ratio DCE/TCEA was about 25:1. These conversions were NADPH-dependent and were inhibited by air, CO and metyrapone. In the presence of SKF 525-A, DCE formation was inhibited by 47%. Microsomes from untreated or beta-naphthoflavone-treated rats were 70-90% less active than microsomes from phenobarbital-treated rats. The Km was 0.50 mM and the Vmax was 66 nmol min-1 mg-1 protein for DCE formation. The results are consistent with the proposal that 1,1,1,2-tetrachloroethane is reduced by hepatic cytochrome(s) P-450 to a free radical intermediate which, for the most part, remains closely associated with the enzyme, is reduced further and undergoes beta-elimination of a chloride ion to form DCE. The occurrence of this reductive pathway in vivo was demonstrated by the quantitation of DCE and TCEA in blood from rats treated with 1,1,1,2-tetrachloroethane.